A report (The Cancer Survival In England For Patients Diagnosed Between 2015 and 2019 publication), uses National Cancer Registration and Analysis Service (NCRAS) data, from NHS Digital shows that the 5-year cancer survival rate for 0 - 14 year olds increased over time, from 76.2% in 2002 to 85.2% in 2019, its highest recorded level. This increase also held true for that age group across 1-year survival rates, from 89.7% in 2002 to 93.2% in 2019. The 10-year survival rates have also seen an increase, from 74.6% in 2002 to 81.9% in 2019.
Childhood cancers accounted for 0.3% of all new cancer diagnosis registered in 2019, with the majority of cases being either leukaemia, malignant neoplasms of the brain or non-Hodgkin lymphoma.
Adult cancers that were newly diagnosed between the 2015 and 2019 calendar years and in children that were newly diagnosed between 2002 and 2019, were included in the survey. The breakdown included adult survival by geography, sex, deprivation and diagnosis stage.
For the first time deprivation breakdowns have been included in the report. This shows that for most cancer types, the net survival rate was lowest in the most deprived areas and highest in the least deprived. The largest deprivation difference in 1-year age standardised net survival rates, was seen in women, with bladder cancer, where the variation was 13.4% between those women living in the most deprived areas (58.4%) and those in the least deprived areas (71.8%).
The report also shows for cancers diagnosed between 2015 and 2019, that skin cancer had the highest 5-year age standardised net survival rate (94.8%). Pancreatic cancer and mesothelioma had the lowest 5-year age standardised net survival rates, at 7.8% and 6.3% respectively.
The increase and decrease in 5-year survival for several cancers were also averaged over the 10 different reporting periods for patients diagnosed 2006-10 and 2015-19. This showed that for both males and females: the biggest increase in survivability was in myeloma (average increase 1% for men and 1.4% for women). The biggest decrease was in bladder cancer (0.5% for men and 0.6% for women).
The 5-year age standardised net survival by stage ranges from 3.2% for stage 4 lung cancer for males to over 100% for stage 1 melanoma for females.
Chesil Radio fund raises for Prostate Cancer, so watch this space for more information on dates in the coming weeks.